Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.740
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
2.580
-0.160 (-5.84%)
After-hours: Dec 5, 2025, 6:54 PM EST
Treace Medical Concepts Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Treace Medical Concepts stock have an average target of 7.07, with a low estimate of 4.00 and a high estimate of 14.5. The average target predicts an increase of 158.03% from the current stock price of 2.74.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Treace Medical Concepts stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Reiterates $7 → $4 | Hold | Reiterates | $7 → $4 | +45.99% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $6.5 → $5.85 | Hold | Maintains | $6.5 → $5.85 | +113.50% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $8 → $5 | Hold → Sell | Downgrades | $8 → $5 | +82.48% | Nov 7, 2025 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 7, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +155.47% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
216.16M
from 209.36M
Increased by 3.25%
Revenue Next Year
218.48M
from 216.16M
Increased by 1.07%
EPS This Year
-0.81
from -0.90
EPS Next Year
-0.86
from -0.81
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 222.6M | 238.3M | |
| Avg | 216.2M | 218.5M | |
| Low | 207.4M | 201.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.3% | 10.2% | |
| Avg | 3.2% | 1.1% | |
| Low | -0.9% | -6.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.10 | -0.71 | |
| Avg | -0.81 | -0.86 | |
| Low | -0.93 | -1.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.